Cyclic AMP delays neutrophil apoptosis via stabilization of Mcl-1
Cyclic AMP delays neutrophil apoptosis via stabilization of Mcl-1
复制标题
DOI:
10.1016/j.febslet.2006.07.034
复制
发表时间:
2006-08-21
期刊:
影响因子:
3.5
通讯作者:
Kitagawa, Seiichi
中科院分区:
文献类型:
--
作者:
Kato, Takayuki;Kutsuna, Haruo;Kitagawa, Seiichi
Human neutrophils underwent spontaneous apoptosis, which was accompanied by degradation of Mcl-1, but not other anti-apoptotic molecules (cIAP1, cIAP2, A1, survivin and Bcl-2). Spontaneous neutrophil apoptosis and Mcl-1 degradation were prevented by cyclic AMP (CAMP) agonists (dibutyryl cAMP and prostaglandin E-1,), and the effects of cAMP agonists on neutrophils were highly resistant to cycloheximide, a protein synthesis inhibitor, although slight increase in Mcl-1 mRNA expression was induced by cAMP agonists. Proteasome inhibitors (epoxomicin and lactacystin) also prevented spontaneous neutrophil apoptosis and Mcl-1 degradation to the same extent as cAMP agonists, and no additive effect was obtained by combination of cAMP agonists and proteasome inhibitors. These findings suggest that cAMP agonists, like proteasome inhibitors, delay neutrophil apoptosis primarily via stabilization of Mcl-1. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.